UROLOGICAL COMPLICATIONS OF CYCLOPHOSPHAMIDE

被引：161

作者：

LEVINE, LA ^{[1
]}

RICHIE, JP ^{[1
]}

机构：

[1] HARVARD UNIV, BRIGHAM & WOMENS HOSP, PROGRAM UROL, BOSTON, MA 02115 USA

来源：

关键词：

D O I：

10.1016/S0022-5347(17)41173-6

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1063 / 1069

页数：7

共 126 条

[31] SEVERE CYCLOPHOSPHAMIDE HEMORRHAGIC CYSTITIS CONTROLLED WITH PHENOL
DUCKETT, JW
PETERS, PC
DONALDSON, MH
[J]. JOURNAL OF PEDIATRIC SURGERY, 1973, 8 (01) : 55 - 57
[32] THE USE OF SODIUM 2-MERCAPTOETHANE SULFONATE TO PREVENT CYCLOPHOSPHAMIDE CYSTITIS
EHRLICH, RM
FREEDMAN, A
GOLDSOBEL, AB
STIEHM, ER
[J]. JOURNAL OF UROLOGY, 1984, 131 (05) : 960 - 962
[33] PHARMACOTHERAPEUTICS OF PROSTAGLANDIN-E2 AND 15 (S) 15-METHYL PROSTAGLANDIN-F2-ALPHA IN CHRONIC SCHISTOSOMAL BLADDER ULCER - A CLINICO-ENDOSCOPIC STUDY
ELGENDI, MA
NASSAR, SH
TOPPOZADA, M
ABDELRAHEEM, F
[J]. PROSTAGLANDINS, 1982, 24 (01): : 97 - 104
[34] CYCLOPHOSPHAMIDE TREATMENT OF SYSTEMIC LUPUS-ERYTHEMATOSUS - RISK OF BLADDER-CANCER EXCEEDS BENEFIT
ELLIOTT, RW
ESSENHIGH, DM
MORLEY, AR
[J]. BRITISH MEDICAL JOURNAL, 1982, 284 (6323) : 1160 - 1161
[35] Fair W R, 1974, Urology, V3, P573, DOI 10.1016/S0090-4295(74)80250-5
[36] INCIDENCE OF BLADDER-CANCER AFTER CYCLOPHOSPHAMIDE THERAPY
FAIRCHILD, WV
SPENCE, CR
SOLOMON, HD
GANGAI, MP
[J]. JOURNAL OF UROLOGY, 1979, 122 (02) : 163 - 164
[37] FERNBACH D J, 1962, JAMA, V182, P30
[38] FINN GP, 1986, NEW ENGL J MED, V314, P61
[39] FORNI AM, 1964, CANCER, V17, P1348, DOI 10.1002/1097-0142(196410)17:10<1348::AID-CNCR2820171017>3.0.CO
[40] 2-0